IBRX Description — ImmunityBio Inc

ImmunityBio is a clinical-stage biotechnology company developing therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases. Co.'s platforms include: antibody cytokine fusion proteins, which include Anktiva, a class of biopharmaceuticals that enhance the therapeutic potential of cytokines, and promote lymphocyte infiltration at a site of disease, improving immune response; and DNA, RNA, and recombinant protein vaccine technologies, which are for infectious diseases to target viruses, including SARS-CoV-2, and for oncology to deliver common tumor-associated antigens, and neoepitopes (expressed only by cancer cells).

Company Name: 
ImmunityBio Inc
Number of ETFs Holding IBRX: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   IBRX Weight   IBRX Amount 
 XBI   0.22%   $18,621,376         
 VTI   0.00%   $10,236,450         
 VB   0.01%   $8,807,635         
 IWM   0.01%   $7,725,404         
 VXF   0.01%   $6,290,436         
 VBK   0.02%   $5,073,968         
 IWO   0.02%   $2,182,675         
 VHT   0.01%   $1,764,821         
 PTH   0.57%   $1,242,638         
 IDNA   0.64%   $1,094,969         
List of all 27 ETFs holding IBRX »
Quotes delayed 20 minutes

Email EnvelopeFree IBRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (4.00 out of 4)
88th percentile
(ranked higher than approx. 88% of all stocks covered)
Based on data provided by Zacks Investment Research via

ETFs Holding IBRX | ImmunityBio Inc | ETF Channel |

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.